Senior Director, DTP Marketing, HIV Treatment at Gilead Sciences

Foster City, California, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, Healthcare, BiotechnologyIndustries

Requirements

Demonstrated high performance in Direct-to-Patient (DTP) marketing, with the ability to set vision and lead diverse stakeholders
Strategic and analytical thinking to make accountable decisions and prioritize tradeoffs
Deep expertise in pharmaceutical brand implementation, communication planning, and patient activation
Proven track record in pharma/biotech and consumer patient/community marketing
Strong leadership skills encompassing change management, recruitment, and performance management
Excellent interpersonal and communication skills for cross-functional collaboration and influence
Strong executive presence, commanding respect through sound business judgment and clear decision-making
Superior budget management skills, including OPEX forecasting and tracking
Experience developing external relationships that foster brand advocacy
Prior direct experience (implied in context of DTP marketing leadership)

Responsibilities

Leading DTP strategy, launch planning, and the annual patient marketing tactical plan
Developing targeted patient marketing approaches across personal and non-personal channels such as print, digital, social media, out-of-home advertising, and television
Generating and utilizing market research insights to enhance and refine promotional strategies and tactics
Creating culturally competent patient materials and collaborating with community partners and cross-functional teams to amplify the patient voice
Managing the DTP marketing team with responsibilities including hiring, coaching, performance management, and budget oversight
Closely managing integrated promotions and media budget and effectively optimizing execution
Overseeing agency relationships to leverage expertise and ensure campaign effectiveness
Ensuring compliance with all relevant laws, regulations, and policies
Driving bold, creative campaigns that empower patients and inspire communities
Leading a talented team, fostering a culture of inclusion, collaboration, and excellence

Skills

Marketing Strategy

Direct-to-Patient Marketing

HIV Treatment

Campaign Management

Team Leadership

Patient Engagement

Multi-Channel Marketing

Healthcare Marketing

Cultural Competence

Market Insights

Gilead Sciences

Develops and commercializes biopharmaceuticals

About Gilead Sciences

Gilead Sciences focuses on discovering, developing, and commercializing medicines for various medical conditions, including HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular issues. The company conducts extensive research and development to create new therapies, which are then marketed to healthcare providers, hospitals, and pharmacies after receiving regulatory approval. Gilead differentiates itself from competitors through its strong commitment to R&D and strategic partnerships, such as with SAP Ariba, to enhance its operations and product offerings. The company's goal is to improve health equity and access to care globally, working with communities to ensure that its medicines reach those in need.

Foster City, CaliforniaHeadquarters

1987Year Founded

$15,873.6MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Paid family time off and paid parental time off

Generous 401(k) contribution matching

Comprehensive medical plans that cover both physical and mental healthcare

Global Wellbeing Reimbursement

Time Off

Global Volunteer Day

Giving Together Program

Employee Support Programs

Flexible Work Options

Risks

Increased competition in HIV treatment from ViiV Healthcare's expanding drug portfolio.

Regulatory scrutiny over drug pricing could impact Gilead's U.S. market operations.

Patent expirations, like Truvada's, lead to increased generic competition and revenue loss.

Differentiation

Gilead's lenacapavir is recognized as the 2024 Breakthrough of the Year for HIV care.

Partnerships with LEO Pharma and Tubulis enhance Gilead's focus on inflammatory and cancer therapies.

Gilead's commitment to health equity initiatives like COMPASS and HepConnect sets it apart.

Upsides

Gilead's strategic partnerships expand its reach in inflammatory and oncology drug markets.

Investment in digital health technologies enhances Gilead's R&D and patient engagement.

Focus on sustainability improves Gilead's operational efficiency and corporate reputation.

Land your dream remote job 3x faster with AI

Try Jobo Free